Acceder

Publicaciones - INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA

Cargando...
Garcia de Guadiana-Romualdo L, Martinez Martinez M, Rodriguez Mulero MD, Esteban-Torrella P, Hernandez Olivo M, Alcaraz Garcia MJ, Campos-Rodriguez V, Sancho-Rodriguez N, Galindo Martinez M, Alcaraz A, Ros Braquehais MS, Baguena Perez-Crespo C, Ramos Arenas V, Tomas Jimenez C, Consuegra-Sanchez L, Conesa-Hernandez A, Pinera-Salmeron P, Bernal-Morell E. Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients. Int J Infect Dis. 2021 Oct;111:211-218. doi: 10.1016/j.ijid.2021.08.058. Epub 2021 Aug 28. PubMed PMID: 34461254; PubMed Central PMCID: PMC8400460.
AÑO: 2021; IF: 8.4
34461254
El Band JEK, Llorente S, Martinez-Garcia P, Alfaro R, Jimenez-Coll V, Boix F, Galian JA, Martinez-Banaclocha H, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome. Curr Protein Pept Sci. 2021;22(10):745-757. doi: 10.2174/1389203722666210706163149. PubMed PMID: 34967284.
AÑO: 2021; IF: 3.118
34967284
Orkin C, Oka S, Philibert P, Brinson C, Bassa A, Gusev D, Degen O, Garcia JG, Morell EB, Tan DHS, D'Amico R, Dorey D, Griffith S, Thiagarajah S, St Clair M, Van Solingen-Ristea R, Crauwels H, Ford SL, Patel P, Chounta V, Vanveggel S, Cutrell A, Van Eygen V, Vandermeulen K, Margolis DA, Smith KY, Spreen WR. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study. Lancet HIV. 2021 Apr;8(4):e185-e196. doi: 10.1016/S2352-3018(20)30340-4. Erratum In: Lancet HIV. 2021 Dec;8(12):e734. PubMed PMID: 33794181.
AÑO: 2021; IF: 16.07
33794181
Guillamon CF, Gimeno L, Server G, Martinez-Sanchez MV, Escudero JF, Lopez-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martinez-Garcia J, Martinez-Escribano J, Ferri B, Lopez-Alvarez MR, Moreno-Alarcon C, Moya-Quiles MR, Muro M, Minguela A. Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers. Eur Urol Oncol. 2021 Apr;4(2):246-255. doi: 10.1016/j.euo.2019.04.009. Epub 2019 May 14. PubMed PMID: 31411976.
AÑO: 2021; IF: 8.208
31411976
Baragano Raneros A, Rodriguez RM, Bernardo Florez A, Palomo P, Colado E, Minguela A, Suarez Alvarez B, Lopez-Larrea C. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia. Oncoimmunology. 2021 Mar 25;10(1):1897294. doi: 10.1080/2162402X.2021.1897294. PubMed PMID: 33796404; PubMed Central PMCID: PMC8007156.
AÑO: 2021; IF: 7.723
33796404
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA